BlogReports: Data on Vioxx was misusedAn analysis of court documents revealed that many Vioxx studies were written by Merck & Co.employees or paid consultants. The drug industry appears to treat scientific data as if they were a marketing tool, according to Bruce Psaty a co-author of one of the JAMA articles. "That's not appropriate." Vioxx evidence comes from two companies -sponsored trials designed to test whether Vioxx could slow the progression to Alzheimer's. Studies found that patients on Vioxx were three times more likely to die of any cause than patients taking placebo.There were 34 deaths among 1,069 Vioxx patients and 12 deaths among 1,078 placebo patients in both studies. Merck & Co. took Vioxx off the market in 2004 after researchers linked the drug to an increased risk of heart attacks and strokes http://www.usatoday.com/news/health/2008-04-15-vioxx-drug-conflicts_N.htm?loc=interstitialskip
Studies found that patients on Vioxx were three times more likely to die of any cause than patients taking placebo.There were 34 deaths among 1,069 Vioxx patients and 12 deaths among 1,078 placebo patients in both studies
Topics
Civil Lawsuit Cases Recent UpdatesAugust 07, 2008 August 01, 2008 July 24, 2008 July 17, 2008 July 09, 2008 |
